0001035267-24-000087.txt : 20240229
0001035267-24-000087.hdr.sgml : 20240229
20240229191715
ACCESSION NUMBER: 0001035267-24-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240228
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOHR MARSHALL
CENTRAL INDEX KEY: 0001252986
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30713
FILM NUMBER: 24706221
MAIL ADDRESS:
STREET 1: C/O INTUITIVE SURGICAL, INC
STREET 2: 1266 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC
CENTRAL INDEX KEY: 0001035267
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770416458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
BUSINESS PHONE: 4085232100
MAIL ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-02-28
0
0001035267
INTUITIVE SURGICAL INC
ISRG
0001252986
MOHR MARSHALL
1020 KIFER ROAD
SUNNYVALE
CA
94086
0
1
0
0
Executive VP Global Business S
1
Common Stock
2024-02-28
4
M
0
13530
242.3367
A
40407
D
Common Stock
2024-02-28
4
S
0
13530
385.0805
D
26877
D
Common Stock
2024-02-28
4
M
0
13530
177.9867
A
40407
D
Common Stock
2024-02-28
4
S
0
13530
385.0805
D
26877
D
Common Stock
2024-02-28
4
M
0
10500
166.6233
A
37377
D
Common Stock
2024-02-28
4
S
0
10500
385.0805
D
26877
D
Common Stock
2024-02-28
4
M
0
12750
174.2567
A
39627
D
Common Stock
2024-02-28
4
S
0
12750
385.0805
D
26877
D
Common Stock
2024-02-28
4
M
0
12750
139.52
A
39627
D
Common Stock
2024-02-28
4
S
0
12750
385.0805
D
26877
D
Common Stock
2024-02-28
4
M
0
22500
109.4856
A
49377
D
Common Stock
2024-02-28
4
S
0
14620
385.0919
D
34757
D
Common Stock
2024-02-28
4
M
0
22500
79.6378
A
57257
D
Common Stock
2024-02-28
4
S
0
13750
385.0794
D
43507
D
Common Stock
2024-02-28
4
M
0
11250
76.9989
A
54757
D
Common Stock
2024-02-28
4
S
0
6860
385.0815
D
47897
D
Common Stock
2024-02-28
4
M
0
10500
182.8333
A
58397
D
Common Stock
2024-02-28
4
S
0
10500
385.0805
D
47897
D
Common Stock
2024-02-29
4
M
0
2253
0.0
A
50150
D
Common Stock
2024-02-29
4
F
0
1142
386.59
D
49008
D
Common Stock
2024-02-29
4
M
0
1003
0.0
A
50011
D
Common Stock
2024-02-29
4
F
0
509
386.59
D
49502
D
Common Stock
100353
I
by Trust
Non-Qualified Stock Option (right to buy)
76.9989
2024-02-28
4
M
0
11250
0.0
D
2026-08-15
Common Stock
11250
0
D
Non-Qualified Stock Option (right to buy)
79.6378
2024-02-28
4
M
0
22500
0.0
D
2027-02-15
Common Stock
22500
0
D
Non-Qualified Stock Option (right to buy)
109.4856
2024-02-28
4
M
0
22500
0.0
D
2027-08-15
Common Stock
22500
0
D
Non-Qualified Stock Option (right to buy)
139.52
2024-02-28
4
M
0
12750
0.0
D
2028-02-15
Common Stock
12750
0
D
Non-Qualified Stock Option (right to buy)
166.6233
2024-02-28
4
M
0
10500
0.0
D
2029-08-15
Common Stock
10500
0
D
Non-Qualified Stock Option (right to buy)
174.2567
2024-02-28
4
M
0
12750
0.0
D
2028-08-15
Common Stock
12750
0
D
Non-Qualified Stock Option (right to buy)
177.9867
2024-02-28
4
M
0
13530
0.0
D
2030-02-28
Common Stock
13530
0
D
Non-Qualified Stock Option (right to buy)
182.8333
2024-02-28
4
M
0
10500
0.0
D
2029-02-15
Common Stock
10500
0
D
Non-Qualified Stock Option (right to buy)
242.3367
2024-02-28
4
M
0
13530
0.0
D
2030-08-28
Common Stock
13530
0
D
Restricted Stock Units
0.0
2024-02-29
4
M
0
2253
0.0
D
2024-02-28
Common Stock
2253
0
D
Restricted Stock Units
0.0
2024-02-29
4
M
0
1003
0.0
D
2026-02-28
Common Stock
1003
2004
D
These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 15, 2024.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.
By: Donna Spinola For: Mohr, Marshall L
2024-02-29